138 related articles for article (PubMed ID: 6203202)
1. Prostatic origin of metastases: immunoperoxidase localization of prostate-specific antigen.
Ghazizadeh M; Kagawa S; Maebayashi K; Izumi K; Kurokawa K
Urol Int; 1984; 39(1):9-12. PubMed ID: 6203202
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical demonstration of prostate-specific antigen in metastases with the use of monoclonal antibody F5.
Papsidero LD; Croghan GA; Asirwatham J; Gaeta J; Abenoza P; Englander L; Valenzuela L
Am J Pathol; 1985 Dec; 121(3):451-4. PubMed ID: 2416221
[TBL] [Abstract][Full Text] [Related]
3. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms.
Nadji M; Tabei SZ; Castro A; Chu TM; Murphy GP; Wang MC; Morales AR
Cancer; 1981 Sep; 48(5):1229-32. PubMed ID: 6168364
[TBL] [Abstract][Full Text] [Related]
4. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
Shah NT; Tuttle SE; Strobel SL; Gandhi L
J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
[TBL] [Abstract][Full Text] [Related]
5. Immunoperoxidase localization of prostate-specific antigen.
Stein BS; Vangore S; Petersen RO; Kendall AR
Am J Surg Pathol; 1982 Sep; 6(6):553-7. PubMed ID: 6183983
[TBL] [Abstract][Full Text] [Related]
6. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer.
Baker WC; Meyers FJ; White RW
J Surg Oncol; 1988 Mar; 37(3):165-7. PubMed ID: 2451087
[TBL] [Abstract][Full Text] [Related]
7. Atypical metastasis from prostate cancer. Clinical utility of the immunoperoxidase technique for prostate-specific antigen.
Tell DT; Khoury JM; Taylor HG; Veasey SP
JAMA; 1985 Jun; 253(24):3574-5. PubMed ID: 2582156
[TBL] [Abstract][Full Text] [Related]
8. Prostatic origin of tumors. An immunohistochemical study.
Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical diagnosis of metastasizing prostatic carcinomas].
Friedmann W; Steffens J; Lobeck H
Onkologie; 1984 Dec; 7(6):337-41. PubMed ID: 6084838
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical diagnosis of the metastasizing prostatic carcinoma.
Steffens J; Friedmann W; Lobeck H
Eur Urol; 1985; 11(2):91-4. PubMed ID: 2408895
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of commercial immunoperoxidase kits for prostatic specific antigen and prostatic specific acid phosphatase.
Svanholm H
Acta Pathol Microbiol Immunol Scand A; 1986 Jan; 94(1):7-12. PubMed ID: 2421532
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
Epstein JI; Eggleston JC
Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
[TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
Stein BS; Vangore S; Petersen RO
Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
[TBL] [Abstract][Full Text] [Related]
15. Prostatic acid phosphatase immunoperoxidase staining of cytologically positive effusions associated with adenocarcinomas of the prostate and neoplasms of undetermined origin.
Broghamer WL; Richardson ME; Faurest S; Parker JE
Acta Cytol; 1985; 29(3):274-8. PubMed ID: 3890441
[TBL] [Abstract][Full Text] [Related]
16. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
18. Argyrophilic prostatic carcinoma. Case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma.
Almagro UA
Cancer; 1985 Feb; 55(3):608-14. PubMed ID: 2578089
[TBL] [Abstract][Full Text] [Related]
19. Orbital metastasis from prostatic carcinoma. Identification by an immunoperoxidase technique.
Winkler CF; Goodman GK; Eiferman RA; Yam LT
Arch Ophthalmol; 1981 Aug; 99(8):1406-8. PubMed ID: 7020662
[TBL] [Abstract][Full Text] [Related]
20. Epididymal metastasis from prostatic adenocarcinoma mimicking adenomatoid tumor.
Rizk CC; Scholes J; Chen SK; Ward J; Romas NA
Urology; 1990 Dec; 36(6):526-30. PubMed ID: 1701066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]